期刊文献+

慢性阻塞性肺疾病急性加重期与稳定期体内NF-κB及可溶性细胞间黏附分子的变化及意义 被引量:1

NF-κB p65 expression and plasma sICAM- 1 levels in COPD patients with acute exacerbation and remission
下载PDF
导出
摘要 目的探讨痰巨噬细胞中NF-κB p65的表达及血浆中可溶性细胞间黏附分子(sICAM-1)在慢性阻塞性肺疾病(COPD)急性加重期、稳定期中的变化与相关性,为临床治疗提供依据。方法选取32例COPD患者(均为急性加重后经治疗转为稳定期)及30例体检健康对照者,诱导痰后采用免疫组织化学染色法检测巨噬细胞中NF-κB p65的表达,同时采用ELISA法检测血浆sICAM-1水平,然后作比较分析。结果与对照者比较,COPD患者急性加重期及稳定期痰巨噬细胞中NF-κB p65的表达和血浆sICAM-1水平均明显较高(P〈0.05或0.01);与稳定期比较,COPD患者急性加重期痰巨噬细胞中NF-κB p65的表达和血浆sICAM-1水平均显著较高(均P〈001)。直线相关分析结果显示,痰巨噬细胞中NF-κB p65的表达与血浆sICAM-1水平呈显著正相关(r=0.538,P〈0.01)。结论NF-κB、sICAM-1在COPD急性加重期呈较高水平表达,两者在COPD气道炎症及阻塞的发生、发展过程中可能起着重要作用,NF-κB可能是通过上调sICAM-1的表达而介导更频繁的白细胞黏附活动发挥作用的。 Objective To investigate the expression of nuclear factor kappa-B (NF - K B) P65 in sputum macropolycytes and plasma soluble intercellular adhesion molecule (sICAM-1) in patients with chronic obstructive pulmonary disease(COPD) during the stage of acute exacerbation and remission. Methods The expression of NF-κ B was detected by immunocytochemical staining and plasma sICAM- 1 was measured by ELISA in 32 COPD patients with acute exacerbation and remission stage, 30 healthy age-matched subjects. Results The positive rate of NF-κB in sputum macropolycytes and the plasma levels of sICAM- 1 in COPD with acute exacerbation were remarkably higher than those in COPD with remission stage (P〈0.01) and in normal controls ( P〈0.05 and 0.01). There was a positive correlation between percentage of positive NF-κB karyotin cell and plasma levels of sICAM- 1 (r=0.538,P〈0.01). Conclusion Up-regulation of NF-κB and high plasma sICAM-1 may be involved in the process of airway inflammation and airway obstruction in COPD.
出处 《浙江医学》 CAS 2010年第1期43-45,共3页 Zhejiang Medical Journal
关键词 慢性阻塞性肺疾病 细胞间黏附分子-1 核因子-ΚB Chronic obstructive pulmonary disease Soluble intercellular adhesion molecule-1 Nuclear factor-kappa B
  • 相关文献

参考文献8

  • 1Yagi O, Aoshiba K, Nagai A. Activation of nuclear factor-kappaB in airway epithelial cells in patients with chronic obstructive pulmonary disease[J]. Clinical investigations, 2006, 73(5): 610-616.
  • 2慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸杂志,2002,25(8):453-460. 被引量:5103
  • 3Pin I, Gibson P G, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation [J]. Thorax, 1992, 47: 25.
  • 4Barnes P J, Shapiro S D, Pauwels R A. Chronic obstructive pulmonary disease, molecular and cellular mechanisms[J]. Eur Respir J, 2003, 22(4): 672-681.
  • 5Wilson S J, Leone B A, Anderson D, et al. Immunohistochemical analysis of the activation of NF-kB and expression of associated cytokines and adhesion molecules in human models of allergic infiammatio[J]. J Pathol, 1999, 189: 265-272.
  • 6Kai M, Beeh M D, Jutta Beier, et al. Long-term repeatability of induced sputum cells and inflammatory markersin stable, moderately severe COPD[J]. Chest, 2003, 123: 778-780.
  • 7Di Stefano A, Caramori G, Oates T, et al. Increasedexpression of nuclear factor- B in bronchial biopsiesfrom smokers and patients with COPD[J]. Eur Respir J, 2002, 20: 556-563.
  • 8Barnes P J, Hansel T. Prospects for new drugs for chronic obstructive pulmonary disease[J]. Lancet, 2004, 364: 985-996.

共引文献5102

同被引文献10

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部